Company Filing History:
Years Active: 2019-2020
Title: Johanna Mosig: Innovator in Respiratory Disorder Treatments
Introduction
Johanna Mosig is a prominent inventor based in Dortmund, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for sleep-related breathing disorders. With a total of 2 patents to her name, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Johanna's latest patents include groundbreaking research on 2-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives. These compounds serve as blockers of task-1 and task-2 channels, specifically targeting the treatment of sleep-related breathing disorders. The application details novel derivatives and their potential use in preparing medicaments for the treatment and prevention of respiratory disorders, including obstructive sleep apneas and snoring. Another significant patent involves substituted perhydropyrrolo[3,4-c]pyrrole derivatives, which also focus on the treatment and prevention of similar respiratory issues.
Career Highlights
Johanna Mosig is currently employed at Bayer Pharma Aktiengesellschaft, where she continues to innovate in the pharmaceutical industry. Her work is characterized by a strong emphasis on developing effective treatments for respiratory disorders, showcasing her commitment to improving patient outcomes.
Collaborations
Johanna collaborates with esteemed colleagues such as Martina Delbeck and Michael Hahn. These partnerships enhance her research efforts and contribute to the advancement of her innovative projects.
Conclusion
Johanna Mosig's contributions to the field of medicinal chemistry are noteworthy, particularly in the area of respiratory disorder treatments. Her patents reflect her dedication to developing effective solutions for patients suffering from sleep-related breathing issues.